Search results for "Guidelines"
Low-dose aspirin associated with 20% increase in risk of anemia among older adults
Analysis of a randomized trial of aspirin in healthy older patients found significantly increased risk of anemia, faster decline in hemoglobin concentrations, and greater decline in ferritin levels with aspirin versus placebo.
https://immattersacp.org/weekly/archives/2023/06/20/1.htm
20 Jun 2023
Sepsis associated with higher cardiovascular risk after hospitalization
A retrospective cohort analysis of 2.25 million U.S. patients found that those with sepsis were at higher risk for all-cause mortality and rehospitalization for each major type of cardiovascular disease event, particularly heart failure, than those without.
https://immattersacp.org/weekly/archives/2023/02/07/4.htm
7 Feb 2023
ACP issues new osteoporosis guidance
The new clinical guideline from the College updates its 2017 recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.
https://immattersacp.org/weekly/archives/2023/01/03/1.htm
3 Jan 2023
Latest COVID-19 research on VTE risk, treatment with metformin, ivermectin, fluvoxamine
Unvaccinated patients may have higher risk of venous thromboembolism (VTE) when mildly ill, one study found, while another showed no effect from metformin, ivermectin, or fluvoxamine. Research supported the safety of the mRNA vaccines, and the NIH updated its treatment guidelines.
https://immattersacp.org/weekly/archives/2022/08/23/4.htm
23 Aug 2022
Adults with subjective cognitive decline were more likely to report 4 modifiable risk factors for Alzheimer's disease
Among survey respondents ages 45 years and older, the most common modifiable risk factor for Alzheimer's disease and related dementias was hypertension (49.9%), followed by not meeting guidelines for aerobic physical activity (49.7%), obesity (35.3%), and diabetes (18.6%).
https://immattersacp.org/weekly/archives/2022/05/31/2.htm
31 May 2022
Quadruple therapy for heart failure cost-effective compared to previous standard of care
Adding a sodium-glucose cotransporter-2 inhibitor to standard care had intermediate cost-effectiveness, but replacing an angiotensin-converting enzyme inhibitor with an angiotensin receptor-neprilysin inhibitor was only borderline cost-effective, a modeling study found.
https://immattersacp.org/weekly/archives/2023/06/13/1.htm
13 Jun 2023
Inappropriate outpatient antibiotics linked to adverse drug events, excess health care costs
Prescriptions of antibiotics to U.S. adults with viral respiratory infections were associated with diarrhea, vulvovaginal candidiasis/vaginitis, and allergies, while use of an inappropriate antibiotic for bacterial infections was associated with nausea, vomiting, and abdominal pain.
https://immattersacp.org/weekly/archives/2022/11/15/4.htm
15 Nov 2022
ACP's commitment to address misinformation and disinformation
The College vigorously supports the use of science and scientific expertise, based on the best available evidence, and remains concerned about the spread of both disinformation and misinformation on social media, public news channels, and other digital channels.
https://immattersacp.org/weekly/archives/2023/02/14/5.htm
14 Feb 2023
New guideline released on diagnosis, management of pancreatic cysts
The American Gastroenterological Association (AGA) released a new guideline last week on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.
https://immattersacp.org/weekly/archives/2015/03/31/1.htm
31 Mar 2015
Treatment pathways compared for diabetic peripheral neuropathy
Amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin were similarly effective for controlling pain, a recent study found.
https://immattersacp.org/weekly/archives/2022/08/30/2.htm
30 Aug 2022